THYMIC CANCER

Clinical trials for THYMIC CANCER explained in plain language.

Never miss a new study

Get alerted when new THYMIC CANCER trials appear

Sign up with your email to follow new studies for THYMIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

New drug combo tested for tough cancers

Disease control Terminated

This early-stage study tested a new drug called SO-C101, either alone or with another drug (pembrolizumab), in 115 people with advanced solid tumors like lung, kidney, or skin cancer. The main goal was to check safety and find the right dose. The study was stopped early, so resul…

Matched conditions: THYMIC CANCER

Phase: PHASE1 • Sponsor: SOTIO Biotech AG • Aim: Disease control

Last updated May 01, 2026 15:58 UTC

THYMIC CANCER

Get alerted when new THYMIC CANCER trials appear

New drug combo tested for tough cancers